{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:55:21Z","timestamp":1783529721271,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Key Technology Support Program","award":["2011BAI03B010602"],"award-info":[{"award-number":["2011BAI03B010602"]}]},{"name":"National Scientific and Technology Major Project","award":["2012ZX090304006"],"award-info":[{"award-number":["2012ZX090304006"]}]},{"name":"National Public Scientific Research","award":["201303111"],"award-info":[{"award-number":["201303111"]}]},{"name":"Project of World Bank loan of Jilin Agricultural Product Quality Safety","award":["2011-Z25"],"award-info":[{"award-number":["2011-Z25"]}]},{"name":"Project Development Plan of Science and Technology of Jilin Province","award":["20130102075JC"],"award-info":[{"award-number":["20130102075JC"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.brainres.2018.05.035","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T16:28:07Z","timestamp":1527092887000},"page":"44-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Monoaminergic and aminoacidergic receptors are involved in the antidepressant-like effect of ginsenoside Rb1 in mouse hippocampus (CA3) and prefrontal cortex"],"prefix":"10.1016","volume":"1699","author":[{"given":"Guo-Li","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Yu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian-Xue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2018.05.035_b0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.physbeh.2016.04.052","article-title":"Involvement of D1 and D2 dopamine receptors in the antidepressant-like effects of selegiline in maternal separation model of mouse","volume":"163","author":"Amiri","year":"2016","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.brainres.2018.05.035_b0010","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2010.04.011","article-title":"Involvement of dopamine receptors in the antidepressant-like effect of melatonin in the tail suspension test","volume":"638","author":"Binfar\u00e9","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2018.05.035_b0015","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00176837","article-title":"Is the forced swimming test a suitable model for revealing antidepressant activity?","volume":"94","author":"Borsini","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2018.05.035_b0020","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/sj.mp.4001362","article-title":"GABAergic dysfunction in mood disorders","volume":"8","author":"Brambilla","year":"2003","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2018.05.035_b0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2011.02.039","article-title":"Antidepressant-like effect of m-trifluoromethyl-diphenyl diselenide in the mouse forced swimming test involves opioid and serotonergic systems","volume":"658","author":"Bruning","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2018.05.035_b0030","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jep.2015.05.055","article-title":"Antidepressant-like and toxicological effects of a standardized aqueous extract of Chrysactinia mexicana A. Gray (Asteraceae) in mice","volume":"171","author":"Cassani","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.brainres.2018.05.035_b0035","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/aje\/kwi301","article-title":"Use of selective serotonin reuptake inhibitors and the risk of breast cancer","volume":"162","author":"Coogan","year":"2005","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.brainres.2018.05.035_b0040","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00726-014-1910-0","article-title":"The modulation of NMDA receptors and L-arginine\/nitric oxide pathway is implicated in the anti-immobility effect of creatine in the tail suspension test","volume":"47","author":"Cunha","year":"2015","journal-title":"Amino Acids"},{"key":"10.1016\/j.brainres.2018.05.035_b0045","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF02246053","article-title":"Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists","volume":"119","author":"Detke","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2018.05.035_b0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejphar.2007.04.028","article-title":"Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor","volume":"568","author":"Dhir","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2018.05.035_b0055","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1098\/rstb.2011.0357","article-title":"A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists","volume":"367","author":"Duman","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. B. Biol. Sci."},{"key":"10.1016\/j.brainres.2018.05.035_b0060","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/sj.npp.1300418","article-title":"Addition of the [alpha]2-antagonist yohimbine to fluoxetine: effects on rate of antidepressant response","volume":"29","author":"Fasula","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2018.05.035_b0065","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2012.02.034","article-title":"Evidence for the involvement of the monoaminergic system, but not the opioid system in the antidepressant-like activity of ellagic acid in mice","volume":"682","author":"Girish","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2018.05.035_b0070","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1007\/s00213-015-4004-0","article-title":"Evidence for the involvement of NMDA receptors in the antidepressant-like effect of nicotine in mouse forced swimming and tail suspension tests","volume":"232","author":"Haj-Mirzaian","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2018.05.035_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/cjpp-2015-0429","article-title":"Fluoxetine reverses the behavioral despair induced by neurogenic stress in mice: role of N-methyl-D-aspartate and opioid receptors","volume":"94","author":"Haj-Mirzaian","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.brainres.2018.05.035_b0080","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejphar.2010.03.019","article-title":"Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of bis selenide in the mouse tail suspension test","volume":"635","author":"Jesse","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2018.05.035_b0085","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neulet.2015.12.006","article-title":"The involvement of NMDA receptor\/NO\/cGMP pathway in the antidepressant like effects of baclofen in mouse force swimming test","volume":"612","author":"Khan","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2018.05.035_b0090","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/aps.2011.181","article-title":"Ginsenoside rb1 selectively inhibits the activity of L-type voltage-gated calcium channels in cultured rat hippocampal neurons","volume":"33","author":"Lin","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.brainres.2018.05.035_b0095","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1017\/S1461145711001386","article-title":"Acute D-serine treatment produces antidepressant-like effects in rodents","volume":"15","author":"Malkesman","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2018.05.035_b0100","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pbb.2014.10.010","article-title":"Antidepressant-like activity of dehydrozingerone: involvement of the serotonergic and noradrenergic systems","volume":"127","author":"Martinez","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2018.05.035_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.brainres.2018.05.035_b0110","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bcp.2013.08.006","article-title":"Animal models of human disease: challenges in enabling translation","volume":"87","author":"Mcgonigle","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.brainres.2018.05.035_b0115","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/0024-3205(77)90155-2","article-title":"Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, alpha-noradrenergic and naloxone receptors","volume":"21","author":"Muller","year":"1977","journal-title":"Life Sci."},{"key":"10.1016\/j.brainres.2018.05.035_b0120","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S0022-3565(25)38235-2","article-title":"Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclo-propanecarboxylic acid","volume":"265","author":"Nowak","year":"1993","journal-title":"J. Pharmacol. Exp. Therapeutics"},{"key":"10.1016\/j.brainres.2018.05.035_b0125","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.biopha.2016.04.026","article-title":"Antidepressant effect of pramipexole in mice forced swimming test: a cross talk between dopamine receptor and NMDA\/nitric oxide\/cGMP pathway","volume":"81","author":"Ostadhadi","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.brainres.2018.05.035_b0130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.brainresbull.2016.03.004","article-title":"Involvement of NMDA receptors and L-arginine\/nitric oxide\/cyclic guanosine monophosphate pathway in the antidepressant-like effects of topiramate in mice forced swimming test","volume":"122","author":"Ostadhadi","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainres.2018.05.035_b0135","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.biopsych.2007.08.010","article-title":"Treatment of SSRI-resistant depression: a meta-analysis comparing within-versus across-class switches","volume":"63","author":"Papakostas","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2018.05.035_b0140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pbb.2015.03.016","article-title":"Protective effects of lithium chloride on seizure susceptibility: involvement of \u03b12-adrenoceptor","volume":"133","author":"Payandemehr","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2018.05.035_b0145","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2147\/DDDT.S62912","article-title":"\u03b3-Aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants","volume":"9","author":"Pehrson","year":"2015","journal-title":"Drug Des. Dev. Therapy"},{"key":"10.1016\/j.brainres.2018.05.035_b0150","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1358\/dot.2005.41.11.904728","article-title":"GABAergic hypotheses of anxiety and depression: focus on GABA-B receptors","volume":"41","author":"Pilc","year":"2005","journal-title":"Drugs Today"},{"key":"10.1016\/j.brainres.2018.05.035_b0155","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1017\/S1461145713001089","article-title":"Antidepressant-like activity of magnesium in the chronic mild stress model in rats: alterations in the NMDA receptor subunits","volume":"17","author":"Pochwat","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2018.05.035_b0160","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1997","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.brainres.2018.05.035_b0165","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.pharep.2015.08.007","article-title":"The role of serotonergic, adrenergic and dopaminergic receptors in antidepressant-like effect","volume":"68","author":"Pytka","year":"2016","journal-title":"Pharmacol. Rep. PR"},{"key":"10.1016\/j.brainres.2018.05.035_b0170","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0028-3908(83)90191-0","article-title":"Temporal sequence of changes in central noradrenergic system of rat after prolonged antidepressant treatment: receptor desensitization and neurotransmitter interactions","volume":"22","author":"Racagni","year":"1983","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2018.05.035_b0175","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0006-3223(99)00041-4","article-title":"Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression","volume":"45","author":"Rajkowska","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2018.05.035_b0180","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2015.01.010","article-title":"Involvement of \u03b11b-adrenoceptors in the anti-immobility effect of imipramine in the tail suspension test","volume":"750","author":"Ribeiro","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2018.05.035_b0185","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00213-012-2722-0","article-title":"NMDA receptor involvement in antidepressant-like effect of pioglitazone in the forced swimming test in mice","volume":"223","author":"Salehi-Sadaghiani","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2018.05.035_b0190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1615\/CritRevNeurobiol.v14.i1.20","article-title":"Impairment of gabaergic transmission in depression: new insights from neuroimaging studies","volume":"14","author":"Sanacora","year":"2000","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.brainres.2018.05.035_b0195","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1176\/appi.ajp.159.4.663","article-title":"Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors","volume":"159","author":"Sanacora","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.brainres.2018.05.035_b0200","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(99)00330-1","article-title":"Antidepressants for the new millennium","volume":"375","author":"Skolnick","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2018.05.035_b0205","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jep.2017.04.009","article-title":"Involvement of serotonergic, noradrenergic and dopaminergic systems in the antidepressant-like effect of ginsenoside Rb1, a major active ingredient of panax ginseng C.A. meyer","volume":"204","author":"Wang","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.brainres.2018.05.035_b0210","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1039\/C6FO00328A","article-title":"The effect of Schisandra chinensis extracts on depression by noradrenergic, dopaminergic, GABAergic and glutamatergic systems in the forced swim test in mice","volume":"7","author":"Yan","year":"2016","journal-title":"Food Funct."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899318302919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899318302919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T18:26:13Z","timestamp":1751653573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899318302919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":42,"alternative-id":["S0006899318302919"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2018.05.035","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monoaminergic and aminoacidergic receptors are involved in the antidepressant-like effect of ginsenoside Rb1 in mouse hippocampus (CA3) and prefrontal cortex","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2018.05.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}